Skip to main content
. 2016 Apr 25;28(2):72–85. doi: 10.11919/j.issn.1002-0829.216016

Table 3. Comparison of mean (sd) results in the intervention group subjects and control group subjects who completed both the baseline and the 6-month follow-up assessments.

scale control group intervention group comparison of control and intervention groups
n baseline at 6 months paired t-test (p) n baseline at 6 months paired t-test (p) at baseline t-test (p) at 6 months t-test (p) at 6 months F-test (p)a
PHQ-9 1239 2.39 (3.42) 3.04 (3.44) 5.64 (<0.001) 3039 1.90 (3.17) 1.81 (3.25) 1.30 (0.194) 4.36 (<0.001) 10.81 (<0.001) 9.98 (<0.001)
GAD-7 1239 1.16 (2.36) 1.74 (2.58) 6.67 (<0.001) 3039 0.88 (2.11) 0.73 (1.96) 3.41 (0.001) 3.65 (<0.001) 12.48 (<0.001) 12.85 (<0.001)
SF-12-PCS 1207 44.9 (8.7) 45.1 (8.0) 0.44 (0.664) 2954 46.2 (8.4) 46.0 (8.5) 1.55 (0.121) 4.26 (<0.001) 3.26 (0.001) 1.03 (0.306)
SF-12-MCS 1207 54.4 (8.8) 51.9 (8.5) 8.03 (<0.001) 2954 55.6 (8.3) 56.5 (7.5) 5.28 (<0.001) 3.87 (<0.001) 16.46 (<0.001) 16.13 (<0.001)

PHQ-9,9-item Patient Health Questionnaire[13]

GAD-7,7-item General Anxiety Disorder scale[14]

SF-12-PCS, Physical Component Summary score computed by weighting items of the 12-item Short Form Health Survey[15]

SF-12-MCS, Mental Component Summary score computed by weighting items of the 12-item Short Form Health Survey[15]

aF-test for analysis of covariance that controls for baseline value and for demographic variables that were different at baseline (i.e., occupation, occurrence of sequelae, and hospital-based treatment in prior 6 months).